Novartis AG
PHARMACEUTICAL USE
Last updated:
Abstract:
The present invention relates to novel methods and pharmaceutical compositions for the treatment of heart failure in a patient.
Status:
Application
Type:
Utility
Filling date:
9 Jul 2021
Issue date:
5 May 2022